Ryman Healthcare Ltd (NZSE:RYM)
NZ$ 3.64 -0.02 (-0.55%) Market Cap: 2.50 Bil Enterprise Value: 5.03 Bil PE Ratio: 522.86 PB Ratio: 0.57 GF Score: 59/100

Full Year 2020 Ryman Healthcare Ltd Earnings Presentation Transcript

Jun 11, 2020 / 10:00PM GMT
Release Date Price: NZ$12.29 (-3.26%)
David Kerr
Ryman Healthcare Limited - Independent Chairman of the Board

Presentation
Jun 11, 2020 / 10:00PM GMT

=====================
Corporate Participants
=====================
* David Bennett
Ryman Healthcare Limited - CFO
* David Kerr
Ryman Healthcare Limited - Independent Chairman of the Board
* Gordon MacLeod
Ryman Healthcare Limited - CEO & Secretary

=====================
Conference Call Participants
=====================
* Andrew Steele
Jarden Limited, Research Division - VP of Equity Research
* Jeremy Andrew Simpson
Forsyth Barr Limited - Analyst
* Jeremy Kincaid
UBS Investment Bank, Research Division - Associate Analyst
* Shane Solly
Harbour Asset Management Limited - Director & Portfolio Manager
* Stephen Ridgewell
Craigs Investment Partners Limited, Research Division - Head of Institutional Research

=====================
-

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot